Trial Outcomes & Findings for Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C (NCT NCT01707030)

NCT ID: NCT01707030

Last Updated: 2025-03-21

Results Overview

The number of days on which alcohol was consumed beyond recommended levels in the last 30 days.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

138 participants

Primary outcome timeframe

Baseline, 3 months, and 6 months

Results posted on

2025-03-21

Participant Flow

Participant milestones

Participant milestones
Measure
Web-Based BAI Arm
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care Arm
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Overall Study
STARTED
67
71
Overall Study
COMPLETED
56
54
Overall Study
NOT COMPLETED
11
17

Reasons for withdrawal

Reasons for withdrawal
Measure
Web-Based BAI Arm
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Usual Care Arm
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Overall Study
Death
1
1
Overall Study
Withdrawal by Subject
2
3
Overall Study
Lost to Follow-up
8
13

Baseline Characteristics

Web-based Intervention to Reduce Alcohol Use in Veterans With Hepatitis C

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention: Computer-Based Brief Alcohol Intervention
n=67 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Intervention participants will also receive usual care. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Control: Treatment as Usual
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Total
n=138 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
42 Participants
n=5 Participants
40 Participants
n=7 Participants
82 Participants
n=5 Participants
Age, Categorical
>=65 years
25 Participants
n=5 Participants
31 Participants
n=7 Participants
56 Participants
n=5 Participants
Age, Continuous
64 years
STANDARD_DEVIATION 8.682 • n=5 Participants
63 years
STANDARD_DEVIATION 7.212 • n=7 Participants
63.5 years
STANDARD_DEVIATION 8.023 • n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
0 Participants
n=7 Participants
5 Participants
n=5 Participants
Sex: Female, Male
Male
62 Participants
n=5 Participants
71 Participants
n=7 Participants
133 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Asian and/or Pacific Islander
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Black/African Amerian
21 Participants
n=5 Participants
20 Participants
n=7 Participants
41 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · White/Caucasion, not of Hispanic origin
25 Participants
n=5 Participants
28 Participants
n=7 Participants
53 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
9 Participants
n=5 Participants
15 Participants
n=7 Participants
24 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Other
6 Participants
n=5 Participants
6 Participants
n=7 Participants
12 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Declined to State/Unknown
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Race/Ethnicity · American Indian or Alaskan Native
3 Participants
n=5 Participants
0 Participants
n=7 Participants
3 Participants
n=5 Participants
Region of Enrollment
United States
67 Participants
n=5 Participants
71 Participants
n=7 Participants
138 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, 3 months, and 6 months

Population: Not all participants were able to complete all follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.

The number of days on which alcohol was consumed beyond recommended levels in the last 30 days.

Outcome measures

Outcome measures
Measure
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Usual Care
n=70 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Change in Days of Unhealthy Alcohol Consumption
Baseline Days of Unhealthy Alcohol Consumption
5.46 Unhealthy drinking days in last 30
Standard Deviation 9.24
7.16 Unhealthy drinking days in last 30
Standard Deviation 10.66
Change in Days of Unhealthy Alcohol Consumption
3-mo Days of Unhealthy Alcohol Consumption
2.72 Unhealthy drinking days in last 30
Standard Deviation 6.69
5.56 Unhealthy drinking days in last 30
Standard Deviation 10.68
Change in Days of Unhealthy Alcohol Consumption
6-mo Days of Unhealthy Alcohol Consumption
2.29 Unhealthy drinking days in last 30
Standard Deviation 6.37
4.78 Unhealthy drinking days in last 30
Standard Deviation 9.91

PRIMARY outcome

Timeframe: Baseline, 3 months, and 6 months

Population: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.

The number of days on which alcohol was consumed at any level in the last 30 days.

Outcome measures

Outcome measures
Measure
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Change in Drinking Days
Baseline drinking days
9.39 Number of drinking days in last 30
Standard Deviation 10.44
12.41 Number of drinking days in last 30
Standard Deviation 11.47
Change in Drinking Days
3-mo drinking days
5.20 Number of drinking days in last 30
Standard Deviation 8.09
7.77 Number of drinking days in last 30
Standard Deviation 10.78
Change in Drinking Days
6-mo drinking days
4.61 Number of drinking days in last 30
Standard Deviation 7.66
8.26 Number of drinking days in last 30
Standard Deviation 10.67

SECONDARY outcome

Timeframe: Baseline, 3 months, and 6 months

Population: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.

The number of standard drinks (0.5 ounce ethanol equivalent) consumed on those days that an individual drank in the last 30 days.

Outcome measures

Outcome measures
Measure
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Change in Drinks Per Drinking Day
Baseline Drinks per Drinking Day
3.57 Drinks per Drinking Day
Standard Deviation 3.90
3.72 Drinks per Drinking Day
Standard Deviation 3.69
Change in Drinks Per Drinking Day
3-mo Drinks per Drinking Day
2.29 Drinks per Drinking Day
Standard Deviation 2.47
2.17 Drinks per Drinking Day
Standard Deviation 2.17
Change in Drinks Per Drinking Day
6-mo Drinks per Drinking Day
1.98 Drinks per Drinking Day
Standard Deviation 2.85
1.87 Drinks per Drinking Day
Standard Deviation 1.90

SECONDARY outcome

Timeframe: Baseline, 3 months, and 6 months

Population: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.

Symptoms of psychological distress will be measured using the Patient Health Questionnaire (PHQ-9). The PHQ-9 provides an assessment of depression severity. The minimum value is 0 and the maximum value is 27. Lower scores are better. The reliability, validity, and clinical utility of the PHQ-9 instrument are well-established.

Outcome measures

Outcome measures
Measure
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Change in Symptoms of Psychological Distress (PHQ-9)
Baseline PHQ-9
6.00 score on a scale
Standard Deviation 5.70
6.68 score on a scale
Standard Deviation 5.67
Change in Symptoms of Psychological Distress (PHQ-9)
3-mo PHQ-9
6.03 score on a scale
Standard Deviation 5.65
6.91 score on a scale
Standard Deviation 6.86
Change in Symptoms of Psychological Distress (PHQ-9)
6-mo PHQ-9
5.57 score on a scale
Standard Deviation 5.07
7.44 score on a scale
Standard Deviation 7.48

SECONDARY outcome

Timeframe: Baseline, 3 months, and 6 months

Population: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.

The Short Form-12 (SF-12) is a 12-item health survey based on the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) designed to assess two component health status summary scales (physical and mental component summaries) in the general U.S. population . The SF-12 has demonstrated good internal consistency reliability and construct validity. This reflects the physical health component of the SF-12. Scores range from 0-100 and higher scores are better.

Outcome measures

Outcome measures
Measure
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Change in SF-12 Physical Health Composite
Baseline SF-12 Health
40.43 score on a scale
Standard Deviation 12.20
40.49 score on a scale
Standard Deviation 11.43
Change in SF-12 Physical Health Composite
3mo SF-12 Health
39.92 score on a scale
Standard Deviation 12.25
41.59 score on a scale
Standard Deviation 12.30
Change in SF-12 Physical Health Composite
6mo SF-12 Health
42.21 score on a scale
Standard Deviation 10.43
40.75 score on a scale
Standard Deviation 12.45

SECONDARY outcome

Timeframe: Baseline and 12 months

Population: These are the same individuals enrolled in the clinical trial from whom the primary outcomes were assessed.

Total costs in dollars of all VA and non-VA inpatient, outpatient and pharmacy costs.

Outcome measures

Outcome measures
Measure
BAI Arm
n=53 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Usual Care
n=54 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Change in Additional Care
42412 US Dollars
Standard Error 5381
51667 US Dollars
Standard Error 8611

OTHER_PRE_SPECIFIED outcome

Timeframe: Baseline, 3 months, and 6 months

Population: Not all participants were able to complete all questions and/or follow-ups in their entirety. We used an analytical approach that used all available data for the participants for the regression analysis even if participants did not complete all the follow-ups.

The Short Form-12 (SF-12) is a 12-item health survey based on the Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) designed to assess two component health status summary scales (physical and mental component summaries) in the general U.S. population. The SF-12 has demonstrated good internal consistency reliability and construct validity. This reflects the mental health component of the SF-12. Scores range from 0-100 and higher scores are better.

Outcome measures

Outcome measures
Measure
BAI Arm
n=67 Participants
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms. Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Usual Care
n=71 Participants
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
Change in SF-12 Mental Health Composite
Baseline SF-12 Mental Health
49.10 score on a scale
Standard Deviation 12.72
48.91 score on a scale
Standard Deviation 11.87
Change in SF-12 Mental Health Composite
3mo SF-12 Mental Health
50.83 score on a scale
Standard Deviation 9.94
49.25 score on a scale
Standard Deviation 11.62
Change in SF-12 Mental Health Composite
6 mo SF-12 Mental Health
50.63 score on a scale
Standard Deviation 10.59
48.51 score on a scale
Standard Deviation 12.77

Adverse Events

Intervention: Web-Based BAI Arm

Serious events: 1 serious events
Other events: 0 other events
Deaths: 1 deaths

Control: Usual Care Arm

Serious events: 1 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
Intervention: Web-Based BAI Arm
n=67 participants at risk
Receiving a web-based brief intervention for alcohol problems Web-Based Brief Alcohol Intervention: Participants report their alcohol use and problems on line and receive feedback comparing them to national norms.
Control: Usual Care Arm
n=71 participants at risk
In usual care, Hepatitis C clinic staff will sometimes discuss alcohol use with patients, and this will be the experience of some of the controls Usual Care: All patients will be receiving care in a Hepatitis C clinic. In some cases clinicians may counsel them on alcohol problems.
General disorders
Death
1.5%
1/67 • Number of events 1 • Adverse event data were collected for 4 years.
0.00%
0/71 • Adverse event data were collected for 4 years.
Renal and urinary disorders
Death
0.00%
0/67 • Adverse event data were collected for 4 years.
1.4%
1/71 • Number of events 1 • Adverse event data were collected for 4 years.

Other adverse events

Adverse event data not reported

Additional Information

Dr. Micheal Cucciare

Department of Veterans Affairs

Phone: 501-257-1068

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place